Average Co-Inventor Count = 4.72
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ucb Pharma, S.a. (14 from 179 patents)
2. Ucb Biopharma Sprl (13 from 138 patents)
3. Ucbbiopharma Srl (6 from 109 patents)
4. Sanofi (4 from 1,454 patents)
5. Celltech R&d Limited (3 from 68 patents)
6. Other (1 from 832,843 patents)
7. Katholieke Universiteit Leuven, Ku Leuven R&d (1 from 238 patents)
37 patents:
1. 11912721 - Fused pentacyclic imidazole derivatives
2. 11458124 - Spirocyclic indane analogues as IL-17 modulators
3. 10980814 - Fused pentacyclic imidazole derivatives as modulators of TNF activity
4. 10953019 - Fused pentacyclic imidazole derivatives as modulators of TNF activity
5. 10906919 - Fused pentacyclic imidazole derivatives
6. 10883996 - Methods of identifying signaling modulators of the trimeric TNFa
7. 10202405 - Fused pentacyclic imidazole derivatives
8. 10053464 - Triazolopyridazine derivatives as modulators of TNF activity
9. 9957255 - Benzotriazole derivatives as modulators of TNF activity
10. 9932342 - Imidazopyrimidine derivatives as modulators of TNF activity
11. 9902720 - Pyrazolopyridine derivatives as modulators of TNF activity
12. 9873703 - Imidazopyridazine derivatives as modulators of TNF activity
13. 9868749 - Fused imidazole and pyrazole derivatives as modulators of TNF activity
14. 9850240 - Triazolopyridine derivatives as modulators of TNF activity
15. 9714251 - Imidazotriazine derivatives as modulators of TNF activity